Postvaccinal, Corticosteroid-resistant Bullous Pemphigoid in Infancy: Treatment with Intravenous Immunoglobulin

被引：10

作者：

Ister, Marielle ^{[1
]}

Pouessel, Guillaume ^{[1
]}

Ythier, Hubert ^{[1
]}

Catteau, Benoit ^{[2
]}

Carpentier, Olivier ^{[2
,3
]}

机构：

[1] Victor Provo Hosp, Dept Pediat, Roubaix, France

[2] Lille Univ Hosp, Dept Dermatol, Lille, France

[3] Victor Provo Hosp, Dept Internal Med, Roubaix, France

来源：

PEDIATRIC DERMATOLOGY | 2014年 / 31卷 / 04期

关键词：

VACCINATION;

D O I：

10.1111/pde.12360

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Bullous pemphigoid is an autoimmune subepidermal blistering disorder that typically affects elderly adults but can also occur in childhood. We report on a 3-month-old boy who developed bullous pemphigoid 1 week after the second routine administration of a hexavalent vaccine. The disease was resistant to standard therapies (including oral and topical corticosteroids) but was relieved by intravenous immunoglobulin treatment. There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids).

引用

页码：E94 / E95

页数：2

共 5 条

[1] Childhood bullous pemphigoid developed after the first vaccination [J].